Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site


Click on country-registry for comparison

FlagCountry-registryRegistration periodTotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
China - Hong Kong SAR 1996-200156177.760.954.979.364.360.056.759.1
China - Qidong 1992-20008121.06.84.521.37.14.84.15.4
China - Shangai 1992-199533852.732.227.853.533.830.228.830.4
China - Tianjin 1991-199930976.764.261.677.766.766.068.864.9
India - Bhopal 1991-19953246.931.312.547.532.113.110.412.6
India - Chennai 1990-199943341.927.823.842.328.424.513.616.4
India - Karunagappally 1991-19973860.536.336.361.137.037.136.345.6
India - Mumbai 1992-1994109934.822.015.235.422.916.314.815.5
Singapore 1993-199720568.350.244.868.851.145.935.942.9
Republic of Korea - Busan 1996-200122265.847.741.866.048.042.232.732.7
Republic of Korea - Incheon 1997-200112567.250.250.267.550.750.838.140.3
Republic of Korea - Seoul 1993-199759567.146.441.867.446.842.533.838.5
Thailand - Chiang Mai 1993-19977052.624.220.352.724.320.415.415.4
Thailand - Lampang 1990-200010963.344.039.863.744.540.535.844.1
Thailand - Songkhla 1990-19999970.254.348.170.554.748.634.536.5
Turkey - Izmir 1995-199716178.155.548.279.257.651.452.650.1



Graphs:


Other tables available:

- Table 1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b: Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6: Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9: Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period